Arimidex is now approved to treat EARLY breast cancer

Arimidex is now approved to treat EARLY breast cancer.

Tamoxifen is currently the standard for women with estrogen receptor-positive breast cancer.

Both tamoxifen and Arimidex reduce the effect of estrogen on tumor cells...but they work in different ways. Tamoxifen blocks estrogen receptors...Arimidex suppresses estrogen synthesis.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote